Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dyne Therapeutics Inc shares valued at $471,636 were sold by Kersten Dirk on Oct 18 ’24. At $35.16 per share, Kersten Dirk sold 13,414 shares. The insider’s holdings dropped to 73,225 shares worth approximately $2.14 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kersten Dirk sold 121 shares, netting a total of over 4,242 in proceeds. Following the sale of shares at $35.06 each, the insider now holds 73,104 shares.
Before that, Kersten Dirk had sold 23,671 shares from its account. In a trade valued at $836,770, the Director traded Dyne Therapeutics Inc shares for $35.35 each. Upon closing the transaction, the insider’s holdings decreased to 23,671 shares, worth approximately $2.91 million.
As published in a research note from JP Morgan on October 24, 2024, Dyne Therapeutics Inc [DYN] has been rated down from an Overweight to a Neutral and the price target has been revised to $35 from $43. Analysts at Chardan Capital Markets resumed the stock at ‘”a Buy”‘ outlook in a report released in late May. As of April 30, 2024, Morgan Stanley has initiated its “an Overweight” rating for DYN. Earlier on February 20, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for DYN stock.
Analyzing DYN Stock Performance
During the last five days, there has been a drop of approximately -9.77%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 119.55%. Shares of the company reached a 52-week high of $47.45 on 08/20/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $35.36, while a 200-day SMA reached $31.56. Nevertheless, trading volume fell to 0.71 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Dyne Therapeutics Inc (DYN)
According to the 24-hour chart, there is a support level at 28.59, which, if violated, would cause prices to drop to 27.98. In the upper region, resistance lies at 30.21. The next price resistance is at 31.22. RSI (Relative Strength Index) is 32.79 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.59, which suggests the price will decrease in the coming days. Percent R is at 96.96%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
